Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Denosumab in kidney transplant recipients
NCT03960554Phase 2Terminated
- Start
- Jan 2020
- Primary completion
- Dec 2021
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of denosumab in osteoporosis. Started Jan 2020; status: terminated.
02
Drugs
denosumab
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT03960554.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03960554.